Initial levels of thyroid-stimulating hormone are a poor predictor of autoantibodies.

The relationship between thyroid cancer subtype and metastatic pattern is poorly understood.

Current guidelines recommend a delay of 6-12 months, but no large-scale study had previously analyzed outcomes.

High-risk patients may benefit from more aggressive treatment.

Aggressive RT should be considered as part of a trimodal approach.

Results from a meta-analysis of 39 studies.

Thyroid autoimmunity should prompt screening and intervention for PPD.

The main indication for surgery was patient preference, not disease progression.

Findings from a population-based study.

Data from a case-control study.

Hypothyroidism tied to increased odds of congenital malformation.

No adverse health outcomes when TSH levels are within normal limits.

Findings from a large UK secondary care cohort.

UK population study adds to mounting evidence for the association.